Autopsy report · NCT01899690
Antibiotics and Tissue Expanders in Breast Reconstruction
Cause of deathRegulatory or ethics
“The study was withdrawn prior to IRB approval.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 4
- Sponsor
- Emory University
- Sponsor type
- University, hospital or other
- Conditions
- Complications; Breast Prosthesis, Infection or Inflammation
- Interventions
- antibiotic
- Participants
- 0
Trials that died the same way
- RCT Investigating Pre-cesarean Vaginal Wash of Chlorhexidine vs Povidone-iodine for Patient With Ruptured Amniotic Membrane.
“The study was withdrawn from the IRB” - Low-Level Transcutaneous Vagus Stimulation in ST Segment Elevation Myocardial Infarction: TREAT MI Study
“Study never initiated; withdrawn prior to receiving IRB approval” - Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized COPD Patients
“The study was withdrawn prior to initiation. The protocol was submitted for IRB review but was not approved. No participants were enrolled.” - CPAP Population Management
“The study was withdrawn prior to initiation. The protocol was submitted for IRB review but was not approved, and no participants were enrolled.” - Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
“Study halted prematurely; IRB approval not obtained”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.